TY - JOUR
T1 - Low concentrations of isoflurane abolish motor evoked responses to transcranial electrical stimulation during nitrous oxide/opioid anesthesia in humans
AU - Kalkman, C. J.
AU - Drummond, J. C.
AU - Ribberink, A. A.
PY - 1991
Y1 - 1991
N2 - To study the feasibility of noninvasive monitoring of motor pathways in anesthetized patients, we evaluated the effect of isoflurane on motor evoked responses to constant-voltage transcranial electrical stimulation (tc(e)-MERs). Reproducible tc(e)-MERs were recordable from the tibialis anterior muscle during nitrous oxide/opioid anesthesia in 11 patients. Before the introduction of isoflurane, tc(e)-MER onset latency was 30.8 ± 1.9 ms, and amplitude ranged from 19 μV to 2.6 mV (median, 209 μV). Operating conditions necessitated neuromuscular blockade in three patients before administration of isoflurane. In the remaining eight patients, introduction of isoflurane in low concentrations resulted in an immediate increase in the latency and a decrease in the amplitude of tc(e)-MERs. The tc(e)-MERs were completely obliterated in all subjects at end-tidal isoflurane concentrations between 0.2% and 0.6% (median, 0.24%). After discontinuation of isoflurane, the tc(e)-MER returned in all patients. The authors conclude that, during nitrous oxide/opioid anesthesia, with the stimulus and recording variables used, isoflurane even at very low concentrations precludes recording of tc(e)-MERs.
AB - To study the feasibility of noninvasive monitoring of motor pathways in anesthetized patients, we evaluated the effect of isoflurane on motor evoked responses to constant-voltage transcranial electrical stimulation (tc(e)-MERs). Reproducible tc(e)-MERs were recordable from the tibialis anterior muscle during nitrous oxide/opioid anesthesia in 11 patients. Before the introduction of isoflurane, tc(e)-MER onset latency was 30.8 ± 1.9 ms, and amplitude ranged from 19 μV to 2.6 mV (median, 209 μV). Operating conditions necessitated neuromuscular blockade in three patients before administration of isoflurane. In the remaining eight patients, introduction of isoflurane in low concentrations resulted in an immediate increase in the latency and a decrease in the amplitude of tc(e)-MERs. The tc(e)-MERs were completely obliterated in all subjects at end-tidal isoflurane concentrations between 0.2% and 0.6% (median, 0.24%). After discontinuation of isoflurane, the tc(e)-MER returned in all patients. The authors conclude that, during nitrous oxide/opioid anesthesia, with the stimulus and recording variables used, isoflurane even at very low concentrations precludes recording of tc(e)-MERs.
UR - http://www.scopus.com/inward/record.url?scp=0025858209&partnerID=8YFLogxK
U2 - 10.1213/00000539-199110000-00008
DO - 10.1213/00000539-199110000-00008
M3 - Article
C2 - 1832825
AN - SCOPUS:0025858209
SN - 0003-2999
VL - 73
SP - 410
EP - 415
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
IS - 4
ER -